Drug Metabolism Letters
Title:Alam K et al. (2018) Drug Metabolism Letters; 12, 24-32.
Volume: 12 Issue: 2
Author(s): Tristan M. Sissung, Cindy Chau, Douglas K. Price and William D. Figg*
Affiliation:
- Clinical Pharmacology Program, Office of the Clinical Director, and the Molecular Pharmacology Section, Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD,United States
Export Options
About this article
Cite this article as:
Sissung M. Tristan, Chau Cindy, Price K. Douglas and Figg D. William*, Alam K et al. (2018) Drug Metabolism Letters; 12, 24-32., Drug Metabolism Letters 2018; 12 (2) . https://dx.doi.org/10.2174/1872312812999180724145725
DOI https://dx.doi.org/10.2174/1872312812999180724145725 |
Print ISSN 1872-3128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-0758 |
33
2
Related Articles
-
Reversing Agents for ATP-Binding Cassette (ABC) Transporters: Application in Modulating Multidrug Resistance (MDR)
Current Medicinal Chemistry - Anti-Cancer Agents Epidermal Growth Factor Receptors: A Functional Perspective
Current Radiopharmaceuticals Treatment of Nasopharyngeal Carcinoma: Therapeutic Management and Future View of Epstein-Barr Virus-Targeting Treatment
Current Cancer Therapy Reviews Chemical and Medicinal Versatility of Dithiocarbamates: An Overview
Mini-Reviews in Medicinal Chemistry (1→3)-α-D-Glucans from Aspergillus spp.: Structural Characterization and Biological Study on their Carboxymethylated Derivatives
Current Drug Targets MicroRNAs as Regulators in Normal Hematopoietic and Leukemia Stem Cells: Current Concepts and Clinical Implications
Current Molecular Medicine Potential Gene Therapy Strategies for Cancer Stem Cells
Current Gene Therapy Molecular Targets from VHL Studies into the Oxygen-Sensing Pathway
Current Cancer Drug Targets Iron Chelators for the Treatment of Cancer
Current Medicinal Chemistry Patent Selections:
Recent Patents on Biomarkers Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers
Current Drug Targets Curcumin as an Adjuvant to Breast Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Synthesis of a Tyr-Tyr Dipeptide Library and Evaluation Against Tumor Cells
Medicinal Chemistry Natural and Synthetic Furanocoumarins as Treatment for Vitiligo and Psoriasis
Current Drug Therapy A Retrospective Study on <i>Gloriosa superba</i> and Its Main Active Constituents
The Natural Products Journal Recent Advances on Dark and Light-Activated Cytotoxity of Imidazole- Containing Ruthenium Complexes
Mini-Reviews in Medicinal Chemistry Cancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives
Current Cancer Drug Targets Subject Index To Volune 2
Current Cancer Therapy Reviews Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer
Current Pharmaceutical Biotechnology One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?
Endocrine, Metabolic & Immune Disorders - Drug Targets